Results were published online on Sept. 5, 2019, by Clinical Infectious Diseases. ... Infectious disease consults increased by 40.2% (15.4 consults per 1,000 patient-days vs.
Sit down with the pharmacy director, get microbiology in the room and whoever the infectious diseases physician leader is. ... Trivedi. And if there is no infectious disease physician around, don't despair.
Results were published in the March 1 Clinical Infectious Diseases. In the six controlled studies that met inclusion criteria, there was no significant difference in clinical response between colistin (72% favorable
As a geriatrician and an epidemiologist with an avid interest in infectious diseases, she wondered not only about whether her patients' hands were colonized with multidrug-resistant organisms but also whether ... So she led a study, published in April by
Updated clinical practice guidelines for diagnosing, preventing and treating catheter-associated urinary tract infections (CA-UTIs) were released by the Infectious Diseases Society of America (IDSA). ... The guidelines, published in the March 1 Clinical
New government guidance covers what is acceptable evidence of immunity to measles and how to respond if health care personnel are exposed to the disease.
PIRO score predicted 28-day mortality better than APACHE II score and American Thoracic Society/Infectious Diseases Society of America criteria (area under the receiver-operating characteristic curve, 0.88, ... The study is in the March 1 issue of
That is the recommendation from the Infectious Diseases Society of America (IDSA).
Results were published by Clinical Infectious Diseases on June 8 and appeared in the Oct.
Ceftazidime-avibactam may be ‘reasonable alternative’ to colistin when treating CRE infections, study finds
Results were published online on Sept. 4 by Clinical Infectious Diseases.